CalTrack

Rationale: Calcium transient analysis is central to understanding inherited and acquired cardiac physiology and disease. While the development of novel calcium reporters enables assays of CRISPR/Cas-9 genome edited pluripotent stem cell derived cardiomyocytes (iPSC-CMs) and primary adult cardiomyocytes, existing calcium-detection technologies are often proprietary and require specialist equipment, while open source workflows necessitate considerable user expertise and manual input. Objective: We aimed to develop an easy to use open source, adaptable, and automated analysis pipeline for measuring cellular calcium transients, from image stack to data output, inclusive of cellular identification, background subtraction, photobleaching correction, calcium transient averaging, calcium transient fitting, data collation and aberrant behavior recognition. Methods and Results: We developed CalTrack, a MatLab based algorithm, to monitor fluorescent calcium transients in living cardiomyocytes, including isolated single cells or those contained in 3-dimensional tissues or organoids and to analyze data acquired using photomultiplier tubes or employing line scans. CalTrack uses masks to segment cells allowing multiple cardiomyocyte transients to be measured from a single field of view. After automatically correcting for photobleaching, CalTrack averages and fits a string of transients and provides parameters that measure time to peak, time of decay, tau, Fmax/F0 and others. We demonstrate the utility of CalTrack in primary and iPSC-derived cell lines in response to pharmacological compounds and in phenotyping cells carrying hypertrophic cardiomyopathy variants. Conclusions: CalTrack, an open source tool that runs on a local computer, provides automated high-throughput analysis of calcium transients in response to development, genetic or pharmacological manipulations, and pathological conditions. We expect that CalTrack analyses will accelerate insights into physiologic and abnormal calcium homeostasis that influence diverse aspects of cardiomyocyte biology.

[1]  Ossama K. Abou Hassan,et al.  Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy , 2020, Circulation. Genomic and precision medicine.

[2]  Mariano Vázquez,et al.  In-silico human electro-mechanical ventricular modelling and simulation for drug-induced pro-arrhythmia and inotropic risk assessment , 2020, Progress in biophysics and molecular biology.

[3]  Stefano Severi,et al.  All-Optical Electrophysiology Refines Populations of In Silico Human iPSC-CMs for Drug Evaluation , 2020, Biophysical journal.

[4]  Matthew J. Daniels,et al.  Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca2+ flux caused by thin filament hypertrophic cardiomyopathy mutations , 2020, American journal of physiology. Heart and circulatory physiology.

[5]  J. F. Staples,et al.  Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy , 2020, Circulation.

[6]  C. Denning,et al.  Force and Calcium Transients Analysis in Human Engineered Heart Tissues Reveals Positive Force-Frequency Relation at Physiological Frequency , 2020, Stem cell reports.

[7]  Stefano Severi,et al.  Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block , 2019, eLife.

[8]  Connor N Broyles,et al.  Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations , 2019, Circulation research.

[9]  Jyoti Rao,et al.  SarcTrack , 2019, Circulation research.

[10]  Christine E Seidman,et al.  Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin , 2019, Science Translational Medicine.

[11]  J. Mavárez,et al.  Lessons from a tarantula: new insights into myosin interacting-heads motif evolution and its implications on disease , 2018, Biophysical Reviews.

[12]  J. Seidman,et al.  Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers , 2018, Proceedings of the National Academy of Sciences.

[13]  Joseph M. Muretta,et al.  Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin , 2018, Proceedings of the National Academy of Sciences.

[14]  Matthew J Daniels,et al.  Fluorescent, Bioluminescent, and Optogenetic Approaches to Study Excitable Physiology in the Single Cardiomyocyte , 2018, Cells.

[15]  H. Watkins,et al.  Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling, and stimulate Ca2+-dependent signaling , 2018, The Journal of Biological Chemistry.

[16]  Christine E Seidman,et al.  Differentiation and Contractile Analysis of GFP‐Sarcomere Reporter hiPSC‐Cardiomyocytes , 2018, Current protocols in human genetics.

[17]  Radhika Agarwal,et al.  CRISPR/Cas9‐Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells , 2018, Current protocols in human genetics.

[18]  Godfrey L. Smith,et al.  MUSCLEMOTION , 2017, Circulation research.

[19]  S. Severi,et al.  Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach , 2017, Heart rhythm.

[20]  R. K. Jackson,et al.  PeakCaller: an automated graphical interface for the quantification of intracellular calcium obtained by high-content screening , 2017, BMC Neuroscience.

[21]  Wesley L. McKeithan,et al.  An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes , 2017, Front. Physiol..

[22]  C. D. dos Remedios,et al.  A model of cardiac contraction based on novel measurements of tension development in human cardiomyocytes. , 2017, Journal of molecular and cellular cardiology.

[23]  Vincent L. Butty,et al.  Geometry-dependent functional changes in iPSC-derived cardiomyocytes probed by functional imaging and RNA sequencing , 2017, PloS one.

[24]  S. Komarova,et al.  Systematic Characterization of Dynamic Parameters of Intracellular Calcium Signals , 2016, Front. Physiol..

[25]  Stefano Severi,et al.  Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy , 2016, Journal of molecular and cellular cardiology.

[26]  Christine E. Seidman,et al.  A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice , 2016, Science.

[27]  Jacob E Corn,et al.  Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA , 2016, Nature Biotechnology.

[28]  Ian Parker,et al.  A comparison of fluorescent Ca²⁺ indicators for imaging local Ca²⁺ signals in cultured cells. , 2015, Cell calcium.

[29]  Rebecca A. B. Burton,et al.  Human-based approaches to pharmacology and cardiology: an interdisciplinary and intersectorial workshop , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[30]  Michael Eldar,et al.  Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations , 2015, Journal of cellular and molecular medicine.

[31]  Yoonkey Nam,et al.  NeuroCa: integrated framework for systematic analysis of spatiotemporal neuronal activity patterns from large-scale optical recording data , 2015, Neurophotonics.

[32]  Israel Steinfeld,et al.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells , 2015, Nature Biotechnology.

[33]  David F. Meaney,et al.  Automated quantification of neuronal networks and single-cell calcium dynamics using calcium imaging , 2015, Journal of Neuroscience Methods.

[34]  Nathaniel Huebsch,et al.  Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales. , 2015, Tissue engineering. Part C, Methods.

[35]  F. Levy,et al.  Inhibition of phosphodiesterase‐3 by levosimendan is sufficient to account for its inotropic effect in failing human heart , 2014, British journal of pharmacology.

[36]  F. Fincham,et al.  Long Term Ablation of Protein Kinase A (PKA)-mediated Cardiac Troponin I Phosphorylation Leads to Excitation-Contraction Uncoupling and Diastolic Dysfunction in a Knock-in Mouse Model of Hypertrophic Cardiomyopathy* , 2014, The Journal of Biological Chemistry.

[37]  Michael J Ackerman,et al.  Nature Genetics Advance Online Publication Genetic Association Study of Qt Interval Highlights Role for Calcium Signaling Pathways in Myocardial Repolarization , 2022 .

[38]  P. Lipp,et al.  Genetically encoded Ca2+ indicators in cardiac myocytes. , 2014, Circulation research.

[39]  David J. Greensmith,et al.  Ca analysis: An Excel based program for the analysis of intracellular calcium transients including multiple, simultaneous regression analysis☆ , 2014, Comput. Methods Programs Biomed..

[40]  Stefan R. Pulver,et al.  Ultra-sensitive fluorescent proteins for imaging neuronal activity , 2013, Nature.

[41]  Wei-Zhong Zhu,et al.  Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. , 2013, Stem cells and development.

[42]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[43]  Fabio Cerignoli,et al.  High throughput measurement of Ca²⁺ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry. , 2012, Journal of pharmacological and toxicological methods.

[44]  J. Potter,et al.  Generation and Functional Characterization of Knock-in Mice Harboring the Cardiac Troponin I-R21C Mutation Associated with Hypertrophic Cardiomyopathy* , 2011, The Journal of Biological Chemistry.

[45]  Bo Lu,et al.  Fully-automated image processing software to analyze calcium traces in populations of single cells. , 2010, Cell calcium.

[46]  C. Rueden,et al.  Metadata matters: access to image data in the real world , 2010, The Journal of cell biology.

[47]  Wei Zheng,et al.  Chemical calcium indicators. , 2008, Methods.

[48]  M. Nieminen,et al.  Evidence-based use of levosimendan in different clinical settings. , 2006, European heart journal.

[49]  A. Gomes,et al.  A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin. , 2005, Journal of molecular and cellular cardiology.

[50]  D. Bers,et al.  Modulation of excitation–contraction coupling by isoproterenol in cardiomyocytes with controlled SR Ca2+ load and Ca2+ current trigger , 2004, The Journal of physiology.

[51]  M. Ohkura,et al.  A high signal-to-noise Ca2+ probe composed of a single green fluorescent protein , 2001, Nature Biotechnology.

[52]  G. Hasenfuss,et al.  Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. , 1998, Circulation.

[53]  M. Matsuzaki,et al.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.

[54]  J. Levijoki,et al.  Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. , 1995, Journal of molecular and cellular cardiology.

[55]  N. Kalkkinen,et al.  Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. , 1994, The Journal of biological chemistry.

[56]  M. Shigekawa,et al.  Phosphorylation of ryanodine receptors in rat myocytes during beta-adrenergic stimulation. , 1992, Journal of biochemistry.

[57]  D. Hathaway,et al.  beta-Adrenergic stimulation of phospholamban phosphorylation and Ca2+-ATPase activity in guinea pig ventricles. , 1983, The Journal of biological chemistry.

[58]  D Marr,et al.  Theory of edge detection , 1979, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[59]  Igor R Efimov,et al.  Remodeling of calcium handling in human heart failure. , 2012, Advances in experimental medicine and biology.

[60]  A. Katz,et al.  Regulation of myocardial contractility 1958-1983: an odyssey. , 1983, Journal of the American College of Cardiology.